Gwen A. Melincoff serves as Executive at COLLEGIUM PHARMACEUTICAL, INC, where they oversee executive responsibilities. Since joining the company, Gwen A. Melincoff has executed 9 insider transactions totaling $15.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 3, 2025 involved receiving (via award) 7,500 shares valued at $0.
Gwen A. Melincoff currently holds 7,500 shares of COLLEGIUM PHARMACEUTICAL, INC (COLL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gwen A. Melincoff has been a net buyer of COLL stock. They have purchased $15.4K and sold $0 worth of shares.
Gwen A. Melincoff's most recent insider trade was on Sep 3, 2025, when they sold 7,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 18, 2023 | COLL | $0 | Award | 9,792 | $N/A | Discretionary |
| May 19, 2022 | COLL | $0 | Award | 14,035 | $N/A | Discretionary |
| May 20, 2021 | COLL | $0 | Award | 9,941 | $N/A | Discretionary |
| May 20, 2020 | COLL | $0 | Award | 4,047 | $N/A | Discretionary |
| Nov 19, 2019 | SLNO | $15.4K | Purchase | 10,000 | $1.54 | Discretionary |
| Apr 25, 2019 | COLL | $0 | Award | 4,707 | $N/A | Discretionary |
| May 24, 2018 | COLL | $0 | Award | 2,253 | $N/A | Discretionary |